Article
Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.
Molecular cancer therapeutics - 1 Feb 2015
Chikano Yuri, Domoto Takahiro, Furuta Takuya, Sabit Hemragul, Kitano-Tamura Ayako, Pyko Ilya V, Takino Takahisa, Sai Yoshimichi, Hayashi Yutaka, Sato Hiroshi, Miyamoto Ken-ichi, Nakada Mitsutoshi, Minamoto Toshinari
Abstract excerpt
The failure of current treatment options for glioblastoma stems from their inability to control tumor cell proliferation and invasion. Biologically targeted therapies offer great hope and one promising target is glycogen synthase kinase-3β (GSK3β), implicated in various diseases, including cancer. We previously reported that inhibition of GSK3β compromises the survival and proliferation of glioblastoma cells,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
